| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.995 | 0.003 | 0.996 | Antiinflammatory | 0.996 0.002 DBMET02573 | DBMET02573 | |
| 0.978 | 0 | 0.981 | Lipocortins synthesis agonist | 0.981 0 DBMET02573 | DBMET02573 | |
| 0.973 | 0.001 | 0.973 | Antipruritic | 0.97 0.001 DBMET02573 | ||
| 0.954 | 0 | 0.974 | Glucocorticoid agonist | 0.974 0 DBMET02573 | DBMET02573 | |
| 0.952 | 0.004 | 0.964 | Toll-Like receptor agonist | 0.964 0.004 DBMET02573 | DBMET02573 | |
| 0.951 | 0.004 | 0.963 | Toll-Like receptor 7 agonist | 0.963 0.004 DBMET02573 | DBMET02573 | |
| 0.892 | 0.001 | 0.896 | Immunosuppressant | 0.896 0.001 DBMET02573 | DBMET02573 | |
| 0.89 | 0 | 0.958 | Corticosteroid-like | 0.958 0 DBMET02573 | DBMET02573 | |
| 0.77 | 0 | 0.77 | Arachidonic acid antagonist | 0.618 0 DBMET02573 | ||
| 0.653 | 0.005 | 0.653 | Hypoxia-inducible factor 1 alpha inhibitor | 0.626 0.006 DBMET02573 | ||
| 0.667 | 0.024 | 0.667 | Transcription factor NF kappa B inhibitor | 0.638 0.027 DBMET02573 | ||
| 0.572 | 0.002 | 0.58 | Lipocortins synthesis antagonist | 0.58 0.002 DBMET02573 | DBMET02573 | |
| 0.518 | 0.005 | 0.554 | Interferon gamma antagonist | 0.554 0.004 DBMET02573 | DBMET02573 | |
| 0.491 | 0.077 | 0.491 | Apoptosis agonist | 0.48 0.081 DBMET02573 | ||
| 0.432 | 0.022 | 0.443 | Nitric oxide antagonist | 0.443 0.021 DBMET02573 | DBMET02573 | |
| 0.411 | 0.014 | 0.422 | Sodium/bile acid cotransporter inhibitor | 0.422 0.012 DBMET02573 | DBMET02573 | |
| 0.342 | 0.032 | 0.342 | DNA synthesis inhibitor | 0.328 0.035 DBMET02573 | ||
| 0.345 | 0.066 | 0.345 | Cholesterol antagonist | 0.334 0.071 DBMET02573 | ||
| 0.294 | 0.036 | 0.294 | Platelet adhesion inhibitor | 0.238 0.053 DBMET02573 | ||
| 0.247 | 0.009 | 0.336 | Androgen antagonist | 0.336 0.006 DBMET02573 | DBMET02573 | |
| 0.246 | 0.024 | 0.33 | Interleukin 6 antagonist | 0.33 0.011 DBMET02573 | DBMET02573 | |
| 0.304 | 0.083 | 0.304 | Apoptosis antagonist | 0.303 0.083 DBMET02573 | ||
| 0.219 | 0.003 | 0.281 | Glucocorticoid antagonist | 0.281 0.003 DBMET02573 | DBMET02573 | |
| 0.237 | 0.03 | 0.237 | Lipid peroxidase inhibitor | 0.21 0.038 DBMET02573 | ||
| 0.208 | 0.004 | 0.245 | Androgen agonist | 0.245 0.004 DBMET02573 | DBMET02573 | |
| 0.253 | 0.049 | 0.253 | Anesthetic general | 0.192 0.079 DBMET02573 | ||
| 0.219 | 0.017 | 0.219 | Farnesoid X receptor antagonist | 0.208 0.019 DBMET02573 | ||
| 0.2 | 0.004 | 0.2 | Anabolic | 0.198 0.004 DBMET02573 | ||
| 0.286 | 0.098 | 0.286 | Antithrombotic | 0.211 0.164 DBMET02573 | ||
| 0.198 | 0.02 | 0.198 | Microtubule formation inhibitor | 0.161 0.032 DBMET02573 | ||
| 0.228 | 0.051 | 0.228 | Hepatoprotectant | 0.209 0.06 DBMET02573 | ||
| 0.265 | 0.103 | 0.289 | Interleukin 2 agonist | 0.289 0.082 DBMET02573 | DBMET02573 | |
| 0.215 | 0.055 | 0.215 | P-glycoprotein inhibitor | 0.209 0.058 DBMET02573 | ||
| 0.176 | 0.02 | 0.176 | Antineoplastic alkaloid | 0.129 0.034 DBMET02573 | ||
| 0.238 | 0.09 | 0.238 | Antioxidant | 0.222 0.1 DBMET02573 | ||
| 0.174 | 0.033 | 0.187 | Interleukin 4 antagonist | 0.187 0.027 DBMET02573 | DBMET02573 | |
| 0.147 | 0.013 | 0.166 | Aromatase inhibitor | 0.166 0.011 DBMET02573 | DBMET02573 | |
| 0.143 | 0.013 | 0.176 | Interleukin 5 antagonist | 0.176 0.007 DBMET02573 | DBMET02573 | |
| 0.136 | 0.007 | 0.136 | 5-Alpha-reductase inhibitor | 0.109 0.009 DBMET02573 | ||
| 0.161 | 0.041 | 0.161 | Alkylator | 0.128 0.061 DBMET02573 | ||
| 0.145 | 0.025 | 0.167 | Estrogen antagonist | 0.167 0.018 DBMET02573 | DBMET02573 | |
| 0.119 | 0.017 | 0.125 | Na+ K+ transporting ATPase inhibitor | 0.125 0.014 DBMET02573 | DBMET02573 | |
| 0.163 | 0.061 | 0.278 | NOS3 expression enhancer | 0.278 0.021 DBMET02573 | DBMET02573 | |
| 0.207 | 0.106 | 0.207 | Hypoglycemic | 0.192 0.121 DBMET02573 | ||
| 0.104 | 0.007 | 0.104 | Nitric oxide donor | 0.095 0.011 DBMET02573 | ||
| 0.099 | 0.008 | 0.26 | Aldosterone antagonist | 0.26 0.003 DBMET02573 | DBMET02573 | |
| 0.097 | 0.008 | 0.103 | Heme oxygenase stimulant | 0.103 0.007 DBMET02573 | DBMET02573 | |
| 0.112 | 0.03 | 0.112 | Transcription factor NF kappa B stimulant | 0.11 0.031 DBMET02573 | ||
| 0.089 | 0.01 | 0.179 | Progesterone antagonist | 0.179 0.005 DBMET02573 | DBMET02573 | |
| 0.084 | 0.01 | 0.118 | Mineralocorticoid receptor antagonist | 0.118 0.006 DBMET02573 | DBMET02573 | |
| 0.08 | 0.008 | 0.089 | RNA-directed RNA polymerase stimulant | 0.089 0.007 DBMET02573 | DBMET02573 | |
| 0.15 | 0.087 | 0.15 | Growth hormone agonist | 0.137 0.099 DBMET02573 | ||
| 0.121 | 0.064 | 0.136 | Cholesterol synthesis inhibitor | 0.136 0.052 DBMET02573 | DBMET02573 | |
| 0.075 | 0.024 | 0.075 | Estrogen agonist | 0.073 0.025 DBMET02573 | ||
| 0.105 | 0.055 | 0.112 | Estrogen receptor beta antagonist | 0.112 0.044 DBMET02573 | DBMET02573 | |
| 0.165 | 0.117 | 0.172 | Neurotrophic factor enhancer | 0.172 0.107 DBMET02573 | DBMET02573 | |
| 0.162 | 0.115 | 0.19 | Angiogenesis stimulant | 0.19 0.1 DBMET02573 | DBMET02573 | |
| 0.157 | 0.113 | 0.198 | Interleukin antagonist | 0.198 0.085 DBMET02573 | DBMET02573 | |
| 0.058 | 0.016 | 0.058 | Microtubule stabilization | 0.053 0.024 DBMET02573 | ||
| 0.043 | 0.005 | 0.054 | Progesterone agonist | 0.054 0.004 DBMET02573 | DBMET02573 | |
| 0.085 | 0.054 | 0.108 | Antineoplastic antibiotic | 0.108 0.043 DBMET02573 | DBMET02573 | |
| 0.045 | 0.015 | 0.07 | Glucose-6-phosphate dehydrogenase inhibitor | 0.07 0.005 DBMET02573 | DBMET02573 | |
| 0.103 | 0.074 | 0.103 | Monophenol monooxygenase inhibitor | |||
| 0.026 | 0.001 | 0.028 | Transcortin receptor antagonist | 0.028 0.001 DBMET02573 | DBMET02573 | |
| 0.042 | 0.02 | 0.043 | Estrogen receptor alpha agonist | 0.043 0.019 DBMET02573 | DBMET02573 | |
| 0.102 | 0.084 | 0.121 | Interleukin 2 antagonist | 0.121 0.043 DBMET02573 | DBMET02573 | |
| 0.085 | 0.072 | 0.085 | Breast cancer-resistant protein inhibitor | 0.082 0.076 DBMET02573 | ||
| 0.092 | 0.084 | 0.092 | Toll-Like receptor 4 antagonist | |||
| 0.012 | 0.01 | 0.012 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.008 DBMET02573 | ||
| 0.065 | 0.084 | 0.079 | Estrogen receptor alpha antagonist | 0.079 0.05 DBMET02573 | DBMET02573 | |
| 0.102 | 0.131 | 0.186 | Diuretic | 0.186 0.05 DBMET02573 | DBMET02573 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |